Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

IST/ECILC stock hub

IST/ECILC has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

IST/ECILCis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

62.4B

Istanbul Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

IST/ECILC

In the news

Latest news · IST/ECILC

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 13.7P50 15.1P75 15.3

Trailing P/E29.9

P25 16.6P50 25.2P75 56.6

ROE3.5

P25 -2.4P50 3.5P75 11.2

ROIC-0.9

P25 -0.7P50 4.3P75 13.6

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All IST/ECILC market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

229

Groups with data

Currency

TRY

Showing 229 of 229 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Turkey
Country code	TR
Employees	1,071
Employees Change	-17%
Employees Change Percent	-1.56
Enterprise value	TRY 60.7B
Exchange	Istanbul Stock Exchange
Financial currency	TRY
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	TRAECILC91E0
Last refreshed	2026-05-10
Market cap	TRY 62.4B
Price	TRY 91.05
Price currency	TRY
Rev Per Employee	9,216,662.93x
Sector	Healthcare
Sic	2834
Symbol	ist/ECILC
Website	https://www.eis.com.tr

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	3.35%
EV Earnings	29.07x
EV/FCF	54.57x
EV/Sales	6.15x
FCF yield	1.78%
P/B ratio	1.02x
P/E ratio	29.87x
P/S ratio	6.32x
PE Ratio10 Y	13.58x
PE Ratio3 Y	13.29x
PE Ratio5 Y	11.11x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-7.2%
EBITDA Margin	0.09%
FCF margin	11.27%
Gross margin	32.87%
Gross Profit	TRY 3.2B
Gross Profit Growth	-15.67%
Gross Profit Growth Q	129.33%
Gross Profit Growth3 Y	44.78%
Gross Profit Growth5 Y	61.06%
Net Income	TRY 2.1B
Net Income Growth	55.9%
Net Income Growth Years	1%
Net Income Growth3 Y	-11.2%
Net Income Growth5 Y	45.34%
Pretax Margin	30.21%
Profit Margin	21.16%
Profit Per Employee	TRY 2M
Profitable Years	11
ROA	-0.6
Roa5y	0.13
ROCE	-1.01
ROE	3.49
Roe5y	9.62
ROIC	-0.86
Roic5y	0.26

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	50.65%
Cagr15y	35.64%
Cagr1y	101.56%
Cagr20y	29.99%
Cagr3y	54.41%
Cagr5y	74.47%
Div CAGR10	18.53%
Div CAGR3	62.25%
Div CAGR5	51.42%
EPS Growth	55.9
EPS Growth Years	1
EPS Growth3 Y	-11.2
EPS Growth5 Y	45.34
FCF Growth	-47.38%
FCF Growth Q	-94.77%
FCF Growth5 Y	71.53%
OCF Growth	-47.14%
OCF Growth Q	-92.82%
OCF Growth10 Y	43.62%
OCF Growth5 Y	79.68%
Revenue Growth	-13.98x
Revenue Growth Q	-2.47x
Revenue Growth Quarters	4x
Revenue Growth Years	8x
Revenue Growth3 Y	41.75x
Revenue Growth5 Y	61.12x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	TRY 0.13
Assets	TRY 75B
Cash	TRY 4.8B
Current Assets	TRY 9.7B
Current Liabilities	TRY 4.8B
Debt	TRY 3.2B
Debt EBITDA	TRY 22.24
Debt Equity	TRY 0.05
Debt FCF	TRY 2.84
Equity	TRY 61B
Interest Coverage	-1.17
Liabilities	TRY 14B
Long Term Assets	TRY 65.3B
Long Term Liabilities	TRY 9.1B
Net Cash	TRY 1.7B
Net Cash By Market Cap	TRY 2.7
Net Debt EBITDA	TRY -182
Net Debt Equity	TRY -0.03
Net Debt FCF	TRY -1.52
Tangible Book Value	TRY 58.7B
Tangible Book Value Per Share	TRY 85.61
WACC	5.98

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.01
Inventory Turnover	2.79
Net Working Capital	TRY 2.1B
Quick ratio	1.53
Working Capital	TRY 4.9B
Working Capital Turnover	TRY 2

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Dividend Growth	0%
Dividend Growth Years	5%
Dividend per share	TRY 1.75
Dividend Years	19
Dividend Yield	1.92%
Ex Div Date	2026-05-06
Last Dividend	TRY 1.75
Payout Frequency	Annual
Payout Ratio	65.34%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	5,917.49%
1Y total return	101.46%
200-day SMA	91.08
3Y total return	268.26%
50-day SMA	104.4
50-day SMA vs 200-day SMA	50over200
5Y total return	1,515.83%
All Time High	132.6
All Time High Change	-31.33%
All Time High Date	2026-01-27
All Time Low	0
All Time Low Change	7,587,400%
All Time Low Date	1992-11-02
ATR	3.87
Beta	0.25
Beta1y	-0.03
Beta2y	0.06
Ch YTD	11.31
High	93.3
High52	132.6
High52 Date	2026-01-27
High52ch	-31.33%
Low	87.7
Low52	40.4
Low52 Date	2025-06-23
Low52ch	125.37%
Ma50ch	-12.77%
Price vs 200-day SMA	-0.03%
RSI	43.88
RSI Monthly	60.14
RSI Weekly	46.55
Sharpe ratio	1.44x
Sortino ratio	2.33
Total Return	1.92%
Tr YTD	13.63
Tr15y	9,579.18%
Tr1m	-12.15%
Tr1w	10.52%
Tr3m	-13.94%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	TRY -710.3M
Operating margin	-7.2

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	128,611,000%
Net Borrowing	-868,198,000
Shares Institutions	2.16%
Shares Out	685,260,000
Shares Qo Q	0%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	TRY 1.1B
Average Volume	10,438,276.3x
Bv Per Share	89.08
CAPEX	TRY -330.5M
Ch10y	3,237.6
Ch15y	4,328.5
Ch1m	-13.94
Ch1w	8.26
Ch1y	90.4
Ch20y	7,320.5
Ch3m	-15.69
Ch3y	240.5
Ch5y	1,331.6
Ch6m	12.41
Change	4.18%
Change From Open	3.47
Close	87.4
Days Gap	0.69
Depreciation Amortization	719,579,000
Dollar Volume	2,333,563,789.8
Earnings Date	2026-04-30
EBIT	TRY -710.3M
EBITDA	TRY 9.3M
EPS	TRY 3.05
F Score	3
FCF	TRY 1.1B
FCF EV Yield	1.83x
FCF Per Share	TRY 1.62
Financing CF	-2,274,111,000
Fiscal Year End	December
Founded	1,951
Graham Number	78.16085
Graham Upside	-14.16
Income Tax	TRY 894.2M
Investing CF	4,263,922,000
Is Primary Listing	1
Last Earnings Date	2025-10-27
Last Report Date	2025-12-31
Last Split Date	2016-11-04
Last Split Type	Forward
Lynch Fair Value	TRY 76.2
Lynch Upside	-16.31
Ma150	100.4
Ma150ch	-9.35%
Ma20	91.77
Ma20ch	-0.78%
Net CF	1,402,586,000
Open	88
P FCF Ratio	56.09
P OCF Ratio	43.24
Payment Date	2026-05-08
Position In Range	59.82
Ppne	5,341,272,000
Price Date	2026-05-08
Price EBITDA	TRY 6,733
Ptbv Ratio	1.06
Relative Volume	2.7x
Revenue	9,871,046,000x
Tax By Revenue	9.06x
Tax Rate	29.99%
Tr20y	18,865%
Tr6m	14.75%
Volume	25,629,476
Z Score	2.66

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

IST/ECILC dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+1.9%

$1.75 annual per share

Payout ratio

+65.3%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+51.4%

5 consecutive years of growth

Total shareholder yield

+1.9%

Next ex-dividend date: 2026-05-06

Performance

IST/ECILC stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns IST/ECILC?

Insider, institutional, and short-interest positioning.

Institutional ownership

+2.2%

Share of float held by funds and institutions

Insider ownership

n/a

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

n/a

Negative means the company is buying back shares.

Technical

IST/ECILC momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

43.9

Neutral momentum band

Price vs 200-day MA

-0.0%

50/200-day relationship not available

Beta (5Y)

0.25

Less volatile than the market

Sharpe ratio

1.44

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About IST/ECILC

Hub-level FAQ points readers to the deeper analysis pages.

What is the current ist/ECILC stock rating?

ist/ECILC is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full ist/ECILC analysis?

The full report lives at /stocks/ist/ECILC/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for ist/ECILC?

The latest report frames ist/ECILC around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the ist/ECILC page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.